Synopsis
Synopsis
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1h-benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, Sodium Salt
2. 2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)-1h-benzimidazole
3. Aciphex
4. Dexrabeprazole
5. E 3810
6. E3810
7. Ly 307640
8. Ly-307640
9. Ly307640
10. Pariet
11. Rabeprazole
12. Sodium, Rabeprazole
1. 117976-90-6
2. Rebeprazole Sodium
3. Pariet
4. Aciphex
5. Rabeprazole Sodium Salt
6. Dexrabeprazole Sodium
7. Rabeprazole (sodium)
8. (s)-rabeprazole Sodium Salt
9. Aciphex Sprinkle
10. Ly307640 Sodium
11. Sodium Rabeprazole
12. Rabeprazole Sodium [usan]
13. Idiazole
14. Rabeprazole Na
15. Chebi:8769
16. 171440-19-0
17. Ly-307640
18. E3810
19. E-3810 Sodium
20. Sodium;2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]benzimidazol-1-ide
21. Ly-307640 Sodium
22. 3l36p16u4r
23. 1h-benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, Sodium Salt
24. 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridyl)methyl)sulfinyl)benzimidazole Sodium Salt
25. Nsc-759270
26. Dsstox_cid_24205
27. Dsstox_rid_80118
28. Dsstox_gsid_44205
29. 1h-benzimidazole, 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-, Sodium Salt (1:1)
30. Rabicip
31. Pepcia
32. Aciphex Sodium
33. Ly 307640 Sodium
34. Habeprazole Sodium
35. Sodium 2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)benzo[d]imidazol-1-ide
36. Sodium 2-({[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methyl}sulfinyl)benzimidazol-1-ide
37. Smr000550493
38. Cas-117976-90-6
39. Ncgc00159518-02
40. E 3810
41. Pariete
42. Unii-3l36p16u4r
43. Pariprazole Sodium
44. Dexrabeprazolesodium
45. Rebeprazole Sodium;
46. Aciphex (tn)
47. Pariet (tn)
48. Rebeprazole Sodium Salt
49. Rabeprazole Sodium- Bio-x
50. Mls001165734
51. Mls006010621
52. Schembl140494
53. Rabeprazole Na [vandf]
54. Chembl1200930
55. Dtxsid3044205
56. Rabeprazole Sodium [jan]
57. Hy-b0656a
58. Rabeprazole Sodium (jp17/usp)
59. Ex-a176
60. Hms2093h10
61. Hms2231e04
62. Hms3373b05
63. Rabeprazole Sodium [mart.]
64. Bcp06639
65. Rabeprazole Sodium [usp-rs]
66. Rabeprazole Sodium [who-dd]
67. Tox21_111736
68. Tox21_302317
69. Ac-715
70. Bdbm50247881
71. Mfcd02092688
72. Rabeprazole Sodium Salt [mi]
73. S4665
74. Rabeprazole Sodium, >=98% (hplc)
75. Akos015895734
76. Akos015962116
77. Akos025310160
78. Tox21_111736_1
79. Am81231
80. Ccg-213574
81. Ccg-268423
82. Nsc 759270
83. Rabeprazole Sodium [orange Book]
84. Ncgc00159518-05
85. Ncgc00255838-01
86. Rabeprazole Sodium [ep Monograph]
87. As-13338
88. Br167318
89. Rabeprazole Sodium [usp Monograph]
90. Ft-0631090
91. Ft-0689461
92. R0115
93. C07865
94. D00724
95. F17418
96. 976r906
97. Sr-01000799133
98. J-010726
99. Q-201655
100. Sr-01000799133-2
101. Q27108142
102. [2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methylsulfinyl]benzimidazol-1-yl]sodium
103. Sodium;2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1h-benzimidazole
104. 1h-benzimidazole,2-[[[4-(3-methoxypropoxy)- 3-methyl-2-pyridinyl]methyl]sulfinyl]-,sodium Salt
105. 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole, Sodium Salt
106. Sodium 2-(((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide
Molecular Weight | 381.4 g/mol |
---|---|
Molecular Formula | C18H20N3NaO3S |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 8 |
Exact Mass | 381.11230696 g/mol |
Monoisotopic Mass | 381.11230696 g/mol |
Topological Polar Surface Area | 81.5 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 446 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Aciphex |
PubMed Health | Rabeprazole (By mouth) |
Drug Classes | Antiulcer, Gastric Acid Secretion Inhibitor |
Drug Label | The active ingredient in ACIPHEX Delayed-Release Tablets is rabeprazole sodium, a substituted benzimidazole that inhibits gastric acid secretion. Rabeprazole sodium is known chemically as 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]-methyl]sulfiny... |
Active Ingredient | Rabeprazole sodium |
Dosage Form | Tablet, delayed release |
Route | oral; Oral |
Strength | 20mg |
Market Status | Prescription |
Company | Eisai; Eisai Medcl Res |
2 of 4 | |
---|---|
Drug Name | Rabeprazole sodium |
Drug Label | The active ingredient in ACIPHEX Delayed-Release Tablets is rabeprazole sodium, a substituted benzimidazole that inhibits gastric acid secretion. Rabeprazole sodium is known chemically as 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]-methyl]sulfiny... |
Active Ingredient | Rabeprazole sodium |
Dosage Form | Tablet, delayed release |
Route | Oral |
Strength | 20mg |
Market Status | Prescription |
Company | Mylan Pharms; Kremers Urban Dev; Teva Pharms Usa; Torrent Pharms; Lupin; Dr Reddys Labs |
3 of 4 | |
---|---|
Drug Name | Aciphex |
PubMed Health | Rabeprazole (By mouth) |
Drug Classes | Antiulcer, Gastric Acid Secretion Inhibitor |
Drug Label | The active ingredient in ACIPHEX Delayed-Release Tablets is rabeprazole sodium, a substituted benzimidazole that inhibits gastric acid secretion. Rabeprazole sodium is known chemically as 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]-methyl]sulfiny... |
Active Ingredient | Rabeprazole sodium |
Dosage Form | Tablet, delayed release |
Route | oral; Oral |
Strength | 20mg |
Market Status | Prescription |
Company | Eisai; Eisai Medcl Res |
4 of 4 | |
---|---|
Drug Name | Rabeprazole sodium |
Drug Label | The active ingredient in ACIPHEX Delayed-Release Tablets is rabeprazole sodium, a substituted benzimidazole that inhibits gastric acid secretion. Rabeprazole sodium is known chemically as 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]-methyl]sulfiny... |
Active Ingredient | Rabeprazole sodium |
Dosage Form | Tablet, delayed release |
Route | Oral |
Strength | 20mg |
Market Status | Prescription |
Company | Mylan Pharms; Kremers Urban Dev; Teva Pharms Usa; Torrent Pharms; Lupin; Dr Reddys Labs |
Treatment of duodenal ulcer, Treatment of gastric ulcer, Treatment of gastro-oesophageal reflux disease, Treatment of Helicobacter pylori in patients with peptic ulcer disease, Treatment of Zollinger-Ellison syndrome
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
Proton Pump Inhibitors
Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. (See all compounds classified as Proton Pump Inhibitors.)
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Registrant Name : Leaders Bio Co., Ltd.
Registration Date : 2023-01-19
Registration Number : 20190910-209-J-241(2)
Manufacturer Name : Metrochem API Private Limite...
Manufacturer Address : Plot No. 62/C/6, Pipeline Road, Phase - I, IDA., Jeedimetla, Quthbullapur Mandal Medc...
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Registrant Name : Kyungbo Pharmaceutical Co., Ltd.
Registration Date : 2019-09-10
Registration Number : 20190910-209-J-241
Manufacturer Name : Metrochem API Private Limite...
Manufacturer Address : Plot No. 62/C/6, Pipeline Road, Phase - I, IDA., Jeedimetla, Quthbullapur Mandal Medc...
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Registrant Name : SG Biochem Co., Ltd.
Registration Date : 2022-01-26
Registration Number : 20190910-209-J-241(1)
Manufacturer Name : Metrochem API Private Limite...
Manufacturer Address : Plot No. 62/C/6, Pipeline Road, Phase - I, IDA., Jeedimetla, Quthbullapur Mandal Medc...
Registrant Name : Genuine Science Co., Ltd.
Registration Date : 2021-01-18
Registration Number : 20210118-209-J-822
Manufacturer Name : Kashima Plant, Eisai Co., Lt...
Manufacturer Address : 22 Sunayama, Kamisu-shi, Ibaraki-ken, 314-0255, Japan
Registrant Name : Hana Pharmaceutical Co., Ltd.
Registration Date : 2021-03-23
Registration Number : 20210323-209-J-905
Manufacturer Name : Hana Pharmaceutical Co., Ltd...
Manufacturer Address : 133, Jaekongdan 3-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do
Registrant Name : Hanseochem Co., Ltd.
Registration Date : 2019-10-01
Registration Number : 20191001-209-J-439
Manufacturer Name : Hanseochem Co., Ltd. @Enal D...
Manufacturer Address : 41@D-33, 34 & 35, Poseunggongdan-ro, Poseung-eup, Pyeongtaek-si, Gyeonggi-do, Phase â...
Registrant Name : Ildong Pharmaceutical Co., Ltd.
Registration Date : 2018-12-19
Registration Number : 20181219-209-J-154
Manufacturer Name : Ildong Pharmaceutical Co., L...
Manufacturer Address : 53, Gongdan-ro 98beon-gil, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do@[Starting mat...
Registrant Name : JW Pharmaceutical Co., Ltd.
Registration Date : 2022-06-29
Registration Number : 20220629-209-J-1321
Manufacturer Name : JW Pharmaceutical Co., Ltd.@...
Manufacturer Address : 56 Gyeongje-ro, Siheung-si, Gyeonggi-do, Sihwa Industrial Complex 1ma 301 (Jeongwang-...
Registrant Name : Korea Biochem Pharmaceutical Co., Ltd.
Registration Date : 2023-12-27
Registration Number : 20231227-209-J-1590
Manufacturer Name : Korea Biochem Pharmaceutical...
Manufacturer Address : 204 Sandan-gil, Jeonui-myeon, Sejong Special Self-Governing City
Registrant Name : Daesin Pharmaceutical Co., Ltd.
Registration Date : 2020-10-20
Registration Number : 20201020-209-J-514
Manufacturer Name : Nifty Labs Pvt. Ltd.
Manufacturer Address : Plot No. 50-A,B,G&H, 64-A,B,C&D, 65-A,B,C&D, 66-A&B, 67-A&B, IDA, Kondapally, Ibrahim...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Gastro Retentive Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Gastro Retentive Tablet
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info :
Registration Country : Italy
Brand Name : RABEPRAZOLE THINKS PHARMA
Dosage Form : Gastro-Resistant Tablets
Dosage Strength : 10 mg
Packaging : 14 UNITS 10 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : RABEPRAZOLE THINKS PHARMA
Dosage Form : Gastro-Resistant Tablets
Dosage Strength : 20 mg
Packaging : 14 UNITS 20 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : RABEPRAZOLE DOC GENERIC
Dosage Form : Gastro-Resistant Tablets
Dosage Strength : 20 mg
Packaging : 28 UNITS 20 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Rabeprazole
Dosage Form : Rabeprazole 10Mg 14 Joined' Oral Use
Dosage Strength : 14 cpr gastrores 10 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Switzerland
Brand Name : Rabeprazole Sandoz
Dosage Form : Film-Coated Tablets
Dosage Strength : 20mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Italy
Brand Name : STARAB
Dosage Form : Gastro-Resistant Tablets
Dosage Strength : 20 mg
Packaging : 28 UNITS 20 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Spain
Brand Name : Combix Rabeprazole 10Mg 28 Tablets Gastro-Resistant Efg
Dosage Form : Gastro-Resistant Tablet
Dosage Strength : 10 Mg/Gastro-resistant Tablet
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Spain
Brand Name : Rabeprazole 20 Mg 14 Tablets Aurobindo Gastro-Resistant Efg
Dosage Form : Gastro-Resistant Tablet
Dosage Strength : 20 Mg/Gastro-resistant Tablet
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
Patent Expiration Date : 2012-09-12
Date Granted : 1995-09-12
Brand Name : PARIET
Patent Number : 1336958
Filing Date : 1989-05-02
Strength per Unit : 10mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-09-12
Date Granted : 1995-09-12
Patent Expiration Date : 2013-08-20
Date Granted : 1999-01-05
Brand Name : PARIET
Patent Number : 2104531
Filing Date : 1993-08-20
Strength per Unit : 10mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-08-20
Date Granted : 1999-01-05
Patent Expiration Date : 2012-09-12
Date Granted : 1995-09-12
Brand Name : PARIET
Patent Number : 1336958
Filing Date : 1989-05-02
Strength per Unit : 20mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-09-12
Date Granted : 1995-09-12
Patent Expiration Date : 2013-08-20
Date Granted : 1999-01-05
Brand Name : PARIET
Patent Number : 2104531
Filing Date : 1993-08-20
Strength per Unit : 20mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-08-20
Date Granted : 1999-01-05
Patent Expiration Date : 2007-11-12
Date Granted :
Brand Name :
Patent Number : 1265138
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2007-11-12
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2007-11-12
Date Granted :
Brand Name :
Patent Number : 1265138
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2007-11-12
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?